Trellus Health plc announced the appointment of Joy Bessenger as Chief Financial Officer in a non-Board capacity, effective from September 18, 2023. Joy's appointment follows the appointment of Steve Young, Interim Chief Financial Officer, as full-time CFO of EKF Diagnostics Holdings plc. Joy has been working as a consultant for Trellus Health since late July as part of an orderly handover from Steve.

Joy has worked for over 20 years with both privately and publicly held life sciences and healthcare companies, with significant experience across finance, operations, corporate strategy and development, compliance and governance and strategic communications. Her most recent full-time role was at IMV Inc., where she served as Senior Vice President, Corporate Strategy and Investor Relations. There, she took responsibility for a large portion of the CFO role, working closely with the CEO to develop a new capital markets and corporate strategy, helping to secure a $25m debt facility and engaging with current and potential partners, as well as institutional investors.

From 2017-2019, Joy served as Senior Vice President, Finance and Strategy of IN8bio, where she helped raise a $10 million Series A financing, engaging with new and existing investors. Prior to this, Joy was the Co-Founder and Chief Financial Officer of 3D Forensic Inc., where she raised seed investment from angel investors, and developed a five-year strategic plan.